Stockholm Stock Exchange | Mid Cap
Bonesupport
+21.85%
Latest
+43.60%
3 months
SEBABG Sundal CollierSEB EquitiesCarnegie

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
SEB70 SEKMay 20
+21.85%
ABG Sundal Collier95 SEKMay 19
SEB Equities58 SEKOct -21
Carnegie55 SEKSep -21

About The Company

Bonesupport Holding AB is a Swedish pharmaceutical company that develops and markets the synthetic injectable bone graft substitute Cerament, which is used in the treatment of skeletal injuries. Bonesupport was founded in the early 2000s as a research company in Lund by orthopedist Lars Lidgren. Wikipedia